Previous immunohistochemical and transcriptomic studies report high NQO1 levels in pancreatic tumor tissues and cell lines, with markedly lower abundance in normal or benign pancreatic tissue NQO1 as a therapeutic target [53,54,55]. Here, NQO1 is linked to pancreatic neoplasm.